PhRMA lies to protect pharma profits
World of DTC Marketing
AUGUST 12, 2022
Data were mainly accessible for smaller firms, products in some therapeutic regions, orphan drugs, first-in-class drugs, therapeutic agents that received accelerated approval, and products between 2014 and 2018. It also raises healthcare costs for public and private insurers alike. In my opinion, PhRMA has zero credibility.
Let's personalize your content